ArticleCureus2025
A Scalp Tumor Revealing Metastatic Breast Cancer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Solitary scalp metastasis after surgery for invasive ductal carcinoma of the breast.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scalp metastases in invasive ductal carcinoma of the breast are extremely rare, occurring in less than 1% of patients. In large retrospective studies of cutaneous metastases, only a small proportion of patients with solid tumors develop skin involvement, with breast cancer being the most common source. We report a case of a patient who developed a single metastatic lesion involving the subcutaneous scalp tissue and the median frontal bone, with intracranial extension reaching the right temporo-occipital region, detected 11 years after the initial diagnosis and treatment of the primary breast tumor. This case highlights the importance of considering atypical metastatic sites during long-term follow-up of breast cancer survivors. It discusses the diagnostic and therapeutic challenges posed by such unusual presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.